|
|
Volumn 3, Issue 5, 2010, Pages 289-
|
|
Metabolic clues: Novel directives for broad treatment strategies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADVANCED GLYCATION END PRODUCT;
ANTIDEPRESSANT AGENT;
ANTIOXIDANT;
BIOLOGICAL MARKER;
CELL PROTEIN;
CHOLESTEROL;
CYCLOOXYGENASE 2;
CYCLOPHOSPHAMIDE;
HYPOXIA INDUCIBLE FACTOR 1;
LIPID;
LIPOPOLYSACCHARIDE;
OXYGENASE;
PROBUCOL;
PROTEIN KINASE LKB1;
PYROGEN LIPOPOLYSACHARIDE;
TOXIN;
UNCLASSIFIED DRUG;
BRAIN TEMPERATURE;
BRONCHIOLE;
CANCER CELL CULTURE;
CANCER GROWTH;
CARDIOTOXICITY;
CARDIOVASCULAR SYSTEM;
CELL DAMAGE;
CELL METABOLISM;
CELL MIGRATION;
CHRONIC KIDNEY DISEASE;
DEGENERATIVE DISEASE;
DIABETES MELLITUS;
DIASTOLIC BLOOD PRESSURE;
DISEASE COURSE;
DYSLIPIDEMIA;
EDITORIAL;
HIPPOCAMPUS;
HUMAN;
LUNG CANCER;
METABOLIC SYNDROME X;
NERVE CELL;
OXIDATIVE STRESS;
PANCREAS;
PERICYTE;
PREFRONTAL CORTEX;
PROTEIN EXPRESSION;
PROTEINURIA;
SIGNAL TRANSDUCTION;
SKELETAL MUSCLE;
SYSTOLIC BLOOD PRESSURE;
THERMOGENESIS;
TOBACCO;
UROGENITAL SYSTEM;
ADOLESCENT;
BODY WEIGHT;
DIABETES MELLITUS;
FEMALE;
HUMANS;
MALE;
OBESITY;
|
|
EID: 78650743796
PISSN: 19420900
EISSN: 19420994
Source Type: Journal
DOI: 10.4161/oxim.3.5.14254 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
